Patents by Inventor Mathieu Hubertus M. Noteborn

Mathieu Hubertus M. Noteborn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Apoptin-associating protein
    Patent number: 7741440
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapies, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is completely or partially non-functional.
    Type: Grant
    Filed: July 16, 2007
    Date of Patent: June 22, 2010
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn, Bertram Weiss, Luisella Toschi
  • Apoptin-associating protein
    Patent number: 7256274
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) nonfunctional.
    Type: Grant
    Filed: December 8, 2000
    Date of Patent: August 14, 2007
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn, Bertram Weiss, Luisella Toschi
  • Apoptin-associating protein
    Patent number: 6878692
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) non-functional.
    Type: Grant
    Filed: March 27, 2001
    Date of Patent: April 12, 2005
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn
  • Apoptin-associating protein
    Patent number: 6809189
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeautic possibilities, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) nonfunctional.
    Type: Grant
    Filed: January 17, 2001
    Date of Patent: October 26, 2004
    Assignee: Leadd B.V.
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn, Bertram Weiss
  • Apoptin-associating protein
    Publication number: 20030091996
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) nonfunctional.
    Type: Application
    Filed: December 8, 2000
    Publication date: May 15, 2003
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A.M. Danen-Van Oorschot, Jennifer Leigh Rohn, Bertram Weiss, Luisella Toschi
  • Fusion proteins for specific treatment of cancer and autoimmune diseases
    Publication number: 20020176860
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic substances, for example novel therapeutic (non-)viral vectors or proteinaceous compounds, that contain apoptin in conjunction with cytotoxic agents, especially in those cases when cells are derailed, such as in cancer- and autoimmune-derived cells.
    Type: Application
    Filed: March 29, 2002
    Publication date: November 28, 2002
    Inventors: Mathieu Hubertus, M. Noteborn, Johan Renes, Ying-Hui Zhang
  • Apoptin-associating protein
    Publication number: 20020127553
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example, novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) nonfunctional.
    Type: Application
    Filed: January 17, 2001
    Publication date: September 12, 2002
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn, Bertram Weiss
  • Apoptin-associating protein
    Publication number: 20020019040
    Abstract: The invention relates to the field of apoptosis. The invention provides novel therapeutic possibilities, for example novel combinatorial therapies or novel therapeutic compounds that can work alone, sequentially to, or jointly with Apoptin, especially in those cases wherein p53 is (partly) non-functional.
    Type: Application
    Filed: March 27, 2001
    Publication date: February 14, 2002
    Inventors: Mathieu Hubertus M. Noteborn, Astrid Adriana A. M. Danen-van Oorschot, Jennifer Leigh Rohn